Question - Sudden Hearing Loss
AM-111 Granted Fast-Track Designation
Asked 7 years ago Jakob Hansen 480
Auris Medical's AM-111 drug candidate has been granted fast-track designation by the FDA. The drug which is developed for the treatment of acute sudden hearing loss is currently in phase-III trials. The intratympanic therapy is being investigated in two separate trial arms - the topline results from the first treatment arm are expected by the third quarter of 2017. Read the full news release via the link below.
Sudden Hearing Loss diet. Is there a diet which improves the quality of lif...
Sudden Hearing Loss synonyms
Can people with Sudden Hearing Loss work? What kind of work can they perfor...
What are the best treatments for Sudden Hearing Loss?
What is the prevalence of Sudden Hearing Loss?
Is it advisable to do exercise when affected by Sudden Hearing Loss? Which ...
What is the history of Sudden Hearing Loss?
